Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. VMD

Market Cap: $334.8M

VI

Viemed Healthcare, Inc.

VMD
NASDAQUSD
Purchase VMD
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin57.21%
EBITDA Margin17.78%
EBIT Margin7.75%
Pre-tax Margin7.02%
Net Profit Margin4.81%
Earnings Yield4.31%
Valuation Multiples
Price / Book2.33
Price / Sales1.11
Price / Earnings23.30
PEG4.19
Forward PEG0.74
EV / Sales1.11
EV / EBITDA6.26
EV / Operating Cash Flow5.52
EV / Free Cash Flow11.48
Price / Free Cash Flow11.45
Price / Operating Cash Flow5.53
Cash Flow & Capital
Free Cash Flow / Share$0.76
Operating Cash Flow / Share$1.59
Free Cash Flow Yield8.73%
Capex / Revenue10.46%
Capex / Operating Cash Flow51.90%
Capex / Depreciation1.04
Stock Compensation / Revenue2.97%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio1.13
Quick Ratio1.02
Cash Ratio0.22
Debt / Assets0.06
Debt / Capital0.07
Debt / Equity0.08
Long-Term Debt / Capital0.04
Debt / Market Cap2.54%
Net Debt / EBITDA0.02
Solvency Ratio0.77
Financial Leverage1.42
Efficiency & Working Capital
Asset Turnover1.48
Fixed Asset Turnover3.69
Inventory Turnover24.50
Receivables Turnover9.36
Payables Turnover11.75
Days Sales Outstanding39
Days Inventory Outstanding14.9
Days Payables Outstanding31.07
Operating Cycle53.9
Cash Conversion Cycle22.83
Working Capital Turnover39.75
Returns & Quality
Return on Equity10.30%
Return on Assets7.10%
Return on Invested Capital11.00%
ROCE15.71%
Return on Tangible Assets10.06%
Operating Return on Assets12.23%
Income Quality4.08
Tax Burden0.68
Interest Burden0.91
Balance Sheet & Intrinsic Metrics
Enterprise Value$335.72M
Invested Capital$147.86M
Working Capital$6.07M
Tangible Asset Value$85.87M
Net Current Asset Value$-4.3M
Graham Number$5.67
Graham Net-Net-$0.54
Book Value / Share$3.82
Tangible Book Value / Share$2.25
Cash / Share$0.28
Financial Health Scores
Piotroski Score6
Altman Z-Score6.06
Revenue$301.61M
EBIT$23.37M
Market Cap$333.27M
Working Capital$6.07M
Retained Earnings$108.24M
Total Assets$204.22M
Total Liabilities$58.26M